European review for medical and pharmacological sciences最新文献_第9页

Prestimulation parameters predicting the pregnancy outcomes after IVF-ET in patients with unexplained infertility. 预测不明原因不孕症患者体外受精-胚胎移植后妊娠结局的受精前参数。

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36523

A C Ozturk, B Dilbaz, R Ozelci, S Dilbaz

{"title":"Prestimulation parameters predicting the pregnancy outcomes after IVF-ET in patients with unexplained infertility.","authors":"A C Ozturk, B Dilbaz, R Ozelci, S Dilbaz","doi":"10.26355/eurrev_202407_36523","DOIUrl":"https://doi.org/10.26355/eurrev_202407_36523","url":null,"abstract":"Objective: Assisted Reproductive Technologies (ART) are considered to be the most effective treatment option for unexplained infertility. This study aims to investigate the pregnancy outcomes of women who received in-vitro fertilization-embryo transfer (IVF-ET) treatment for unexplained infertility and the contributing factors affecting these outcomes.Patients and methods: The present study included 789 consecutive women with unexplained infertility who were treated with IVF-ET at the ART Clinic of the Health Sciences University, Ankara Etlik Zübeyde Hanım Gynecology Training and Research Hospital between January 2007 and December 2019. The contributing factors affecting these outcomes, such as body mass index (BMI), basal follicle-stimulating hormone (FSH), and antimullerian hormone (AMH), were evaluated retrospectively.Results: Clinical pregnancy per cycle was 19.8% among patients recruited. No statistically significant difference was detected in terms of age, infertility duration, and BMI of the patients who achieved pregnancy and who failed to get pregnant after IVF-ET treatment. The basal FSH level was found to be significantly lower (p=0.001), and the AMH level was significantly higher in patients who had clinical pregnancy (p=0.001). The basal AMH cut-off value was calculated to be 3.34 ng/mL, and the basal FSH cut-off value was calculated as 7.26 IU/L for the prediction of clinical pregnancy.Conclusions: IVF-ET treatment can be applied as a successful treatment option in unexplained infertility cases. Although the basal FSH and AMH values are not the cut-off values that have high sensitivity and specificity, they are considered to be associated with pregnancy rates.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 13","pages":"3912-3921"},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Retraction Note: Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway. 撤稿说明：白藜芦醇通过阻断 P13K/Akt/e-NOS 通路，保护急性心肌梗死大鼠因缺血再灌注诱发的心肌凋亡。

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36455

X Zhang, L-F Huang, L Hua, H-K Feng, B Shen

{"title":"Retraction Note: Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway.","authors":"X Zhang, L-F Huang, L Hua, H-K Feng, B Shen","doi":"10.26355/eurrev_202407_36455","DOIUrl":"https://doi.org/10.26355/eurrev_202407_36455","url":null,"abstract":"The article \"Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway\", by X. Zhang, L.-F. Huang, L. Hua, H.-K. Feng, B. Shen, published in Eur Rev Med Pharmacol Sci 2019; 23 (4): 1789-1796-DOI: 10.26355/eurrev_201902_17142-PMID: 30840305 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/6A6E686494A160FBE7A1725E5CE30C) regarding figure duplication in Figures 1 and 2A, the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal investigation revealed a figure duplication between the panels AMI and AMI+RSV+LY of Figure 1. The authors were informed about the journal's investigation but remained unresponsive and did not provide the study's raw data. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17142.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 12","pages":"3809"},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141467259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Is there a multidisciplinary role for 5-methyltetrahydrofolate? The obstetric evidence in perspective. 5-甲基四氢叶酸是否具有多学科作用？产科证据透视。

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36526

M Rubini, G Di Minno, E Ferrazzi

{"title":"Is there a multidisciplinary role for 5-methyltetrahydrofolate? The obstetric evidence in perspective.","authors":"M Rubini, G Di Minno, E Ferrazzi","doi":"10.26355/eurrev_202407_36526","DOIUrl":"https://doi.org/10.26355/eurrev_202407_36526","url":null,"abstract":"5-methyltetrahydrofolate (5-MTHF), or its synthetic precursor, folic acid, is traditionally used as a supplement for improving fertility and for the prevention of embryonal neural tube defects. However, in the last decade, starting from the effectiveness of this preventive treatment in the gynecological setting, the use of 5-MTHF was extended to other medical and pathological areas. Thus, there might be a rationale for the use of 5-MTHF for purposes other than the protection of the growing embryo linked to the possible effect of MTHFR variants in different pathological conditions. A narrative review was conducted to provide an overview of the available evidence on the use of 5-MTHF in the obstetric field and to critically discuss the available data regarding the use of 5-MTHF across other different therapeutic areas. Results showed that the use of 5-MTHF in pregnancy presents some advantages if compared with folic acid, such as immediate action, the non-necessity of metabolic activation, and the immediate bioavailability of the mother and fetus. Otherwise, the role of 5-MTHF in the management of cardiovascular risk is still debated due to the multiple confounding factors that characterize this patient setting. A link between folate deficiency in pregnancy and postpartum depression has been proposed, as well as between folate levels and the onset of depression. In conclusion, evidence from the literature supports the additional role of 5-MTHF as a pleiotropic drug with a transversal effect in different therapeutic contexts. With regard to the prevention of cardiovascular disorders, available evidence is not conclusive.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 13","pages":"3934-3945"},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effects of anesthesia and perioperative management on mortality in geriatric orthopedic surgery: a retrospective study of 451 patients. 麻醉和围手术期管理对老年骨科手术死亡率的影响：对 451 名患者的回顾性研究。

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36575

A Atlas, A Y Kaptan, E Büyükfırat, M Tercan, M A Karahan, N Altay

{"title":"Effects of anesthesia and perioperative management on mortality in geriatric orthopedic surgery: a retrospective study of 451 patients.","authors":"A Atlas, A Y Kaptan, E Büyükfırat, M Tercan, M A Karahan, N Altay","doi":"10.26355/eurrev_202407_36575","DOIUrl":"https://doi.org/10.26355/eurrev_202407_36575","url":null,"abstract":"Objective: We aimed to investigate the effects of anesthesia methods and perioperative procedures on mortality in geriatric patients operated for hip fracture.Patients and methods: This retrospective study included patients over 65 years of age who underwent hip fracture surgery. Demographic data, risk scores, perioperative and anesthesia management were analyzed in terms of mortality.Results: Data from 451 patients who were eligible for the study were analyzed. It was determined that there was no difference in mortality between the anesthesia methods administered to the patients in hip fracture surgery (p>0.05). Being male increased the mortality risk by 4.568 times (95% CI: 1.215-17.168), and a one-unit increase in the number of erythrocyte suspensions given perioperatively increased the mortality risk by 2.801 times (95% CI: 1.509-5.197). Additionally, an American Society of Anesthesiologists (ASA) II score increased the mortality risk by 0.120 times (95% CI: 0.021-0.690), and a higher modified Charlson comorbidity index (mCCI) of 5-7 increased the mortality risk by 0.052 times (95% CI: 0.009-0.289).Conclusions: Although high ASA and mCCI scores, male sex, and blood transfusion were associated with mortality in geriatric hip fracture surgery, we found that the method of anesthesia did not affect mortality.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 14","pages":"3993-4002"},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Role of micronutrients in the symptoms of fibromyalgia: a review of the literature and analysis of an Italian female sample. 微量营养素在纤维肌痛症状中的作用：文献综述和意大利女性样本分析。

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36579

M G Tarsitano, G Dolcini, C Pandozzi, F Greco, C Iannuncelli, C Conte, E Giannetta, M Di Franco

{"title":"Role of micronutrients in the symptoms of fibromyalgia: a review of the literature and analysis of an Italian female sample.","authors":"M G Tarsitano, G Dolcini, C Pandozzi, F Greco, C Iannuncelli, C Conte, E Giannetta, M Di Franco","doi":"10.26355/eurrev_202407_36579","DOIUrl":"https://doi.org/10.26355/eurrev_202407_36579","url":null,"abstract":"Objective: Fibromyalgia (FM) is a multifactorial disease characterized principally by chronic, widespread pain impairing a patient's quality of life. The management of FM requires a multidisciplinary approach that combines pharmacological and non-pharmacological strategies. Growing evidence suggests a potential beneficial role of micronutrients such as minerals and vitamins. Overall, the role of these supplements remains controversial, but clinical trials on vitamin D, vitamin B12, magnesium, and iron supplementation seem to provide promising results. The aim of this study was to investigate their role in an Italian female sample.Subjects and methods: An exploratory cross-sectional study was done to assess the association of selected micronutrients with symptoms of FM by using the Fibromyalgia Impact Questionnaire (FIQ) in twenty consecutive female patients with FM. A literature review was also conducted.Results: FIQ results revealed that vitamin D and magnesium deficiency appear to play a role in FM symptoms, mainly in physical function and stiffness. From the literature review, only two studies investigating the role of micronutrients in FM were retrieved.Conclusions: Screening for micronutrient deficiencies in FM patients and supplementing them when levels are low might help counteract FM symptoms.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 14","pages":"4038-4045"},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Chinese patient with Madelung's disease and alcoholic cardiomyopathy: a case report and literature review. 一名患有马德龙病和酒精性心肌病的中国患者：病例报告和文献综述。

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36522

H Zhao, X-L Ma, K Yu, F-H Zhang, S-Q Liu

{"title":"A Chinese patient with Madelung's disease and alcoholic cardiomyopathy: a case report and literature review.","authors":"H Zhao, X-L Ma, K Yu, F-H Zhang, S-Q Liu","doi":"10.26355/eurrev_202407_36522","DOIUrl":"10.26355/eurrev_202407_36522","url":null,"abstract":"Background: Madelung's disease is a rare disorder characterized by massive deposits of excess subcutaneous fat around the neck, shoulders, arms, and other parts of the body. It has a high prevalence among middle-aged alcoholic men in Mediterranean countries and a low incidence in Asian populations. Although patients with Madelung's disease are often associated with a variety of alcohol-induced metabolic disorders, the comorbidity of alcoholic cardiomyopathy is rarely reported, probably because of its low incidence or neglect by clinicians.Case report: A 67-year-old man with a 10-year history of soft fat masses in the neck developed chest tightness and shortness of breath on exertion for the past 2 years. Laboratory tests revealed elevated γ-glutamyl transferase, glucose intolerance, hyperuricemia, hyperlipidemia, and anemia. Computed tomography of the neck showed symmetric nonencapsulated fat deposits, mainly in the anterior cervical regions. Echocardiography showed left heart enlargement and severe global left ventricular systolic dysfunction with an ejection fraction of 31%. Coronary angiography revealed 40-50% stenoses of the left anterior descending and right coronary arteries. After the exclusion of other causes of dilated cardiomyopathy, the patient was finally diagnosed with type I Madelung's disease and alcoholic cardiomyopathy. He underwent lifestyle changes, including reducing his alcohol intake, and received full pharmacological treatment for heart failure. One and a half years later, his cardiac function was partially restored, and all metabolic abnormalities improved except for elevated liver enzymes.Conclusions: Alcohol use disorder should be assessed in patients with newly diagnosed Madelung's disease. Screening for alcoholic cardiomyopathy in alcoholic patients with Madelung's disease is necessary for early detection of cardiac abnormalities and intervention to improve the prognosis of this group of patients.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 13","pages":"3905-3911"},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A nomogram for predicting low cardiac output syndrome in older patients undergoing acute type A aortic dissection surgery. 预测接受急性 A 型主动脉夹层手术的老年患者低心输出量综合征的提名图。

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36578

J-B Wu, L Chen, X Yang, Y Liu, K-Y Chen, L-W Chen

{"title":"A nomogram for predicting low cardiac output syndrome in older patients undergoing acute type A aortic dissection surgery.","authors":"J-B Wu, L Chen, X Yang, Y Liu, K-Y Chen, L-W Chen","doi":"10.26355/eurrev_202407_36578","DOIUrl":"https://doi.org/10.26355/eurrev_202407_36578","url":null,"abstract":"Objective: Low cardiac output syndrome (LCOS) is a dangerous postoperative complication in patients with acute type A aortic dissection (ATAAD). This study aims to develop and evaluate a nomogram model that can reliably identify risk variables for postoperative LCOS in elderly patients suffering from ATAAD.Patients and methods: In this retrospective study, a total of 310 elderly patients with ATAAD admitted to Fujian Medical University Union Hospital were included and categorized into the LCOS and non-LCOS groups. Stepwise logistic regression was used to analyze independent predictors of LCOS, and a nomogram was constructed. The best clinical decision points were found using decision analysis and a clinical impact curve.Results: Postoperative LCOS occurred in 22 (7.1%) of elderly patients with ATAAD. Independent risk factors for postoperative LCOS were age, smoking history, aortic cross-clamp (ACC), coronary heart disease (CHD), and preoperative shock. The nomogram constructed based on the identified risk factors showed good performance.Conclusions: Our results suggest that preventive treatment can be administered when needed when the risk of LCOS in older patients with ATAAD after surgery is >60%. This study contributes to developing a methodology that may improve therapeutic decision-making in older patients and provides insights for assessing the risk of LCOS.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 14","pages":"4029-4037"},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Retraction Note: Fas/FasL induces myocardial cell apoptosis in myocardial ischemia-reperfusion rat model. 撤稿说明：Fas/FasL 在心肌缺血再灌注大鼠模型中诱导心肌细胞凋亡。

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36516

X-M Liu, Z-M Yang, X-K Liu

引用次数: 0

Author Correction: Momordica charantia reduced ovarian ischemia - reperfusion injury by suppressing APAF-1 expression. 作者更正：桃金娘通过抑制 APAF-1 的表达减轻卵巢缺血再灌注损伤

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36586

F Aşır, Ç Özgökce

引用次数: 0

Adiponectin and leptin profiles among obese pregnant women with preeclampsia vs. non-preeclampsia: a systematic review and meta-analysis. 先兆子痫与非先兆子痫肥胖孕妇的脂肪连接蛋白和瘦素概况：系统综述和荟萃分析。

IF 3.3 4区医学

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI: 10.26355/eurrev_202407_36524

A D Nugrahani, M A Aziz, D P J Santoso, A Siddiq, A Y Pramatirta, S Irianti, A Pribadi, A D Anwar, M R A A Syamsunarno

{"title":"Adiponectin and leptin profiles among obese pregnant women with preeclampsia vs. non-preeclampsia: a systematic review and meta-analysis.","authors":"A D Nugrahani, M A Aziz, D P J Santoso, A Siddiq, A Y Pramatirta, S Irianti, A Pribadi, A D Anwar, M R A A Syamsunarno","doi":"10.26355/eurrev_202407_36524","DOIUrl":"10.26355/eurrev_202407_36524","url":null,"abstract":"Objective: Preeclampsia (PE) affects only about 10% of women who meet the criteria for obesity based on their body mass index (BMI). Obesity is suggested to play a role in preeclampsia pathophysiology, and in addition to BMI, associated biomarkers with higher sensitivity and specificity, such as with adipokines from adipose tissue, are needed to enable clinical risk assessment. This study aimed to investigate obese pregnant women with and without PE by comparing clinical profiles and adipokine profiles specific to general adipose tissue (adiponectin and leptin).Materials and methods: This meta-analysis was conducted following the PRISMA and was registered in PROSPERO (CRD42023478706). We utilized Cochrane, Scopus, and PubMed/Medline databases. The Cochrane ROBINS-I instrument was employed to assess the quality of studies. Pooled standard mean difference (SMD) and p-value were analyzed using a random-effects model with the DerSimonian-Laird method, while subgroup analysis with the Chi-square test and the inconsistency index (I2) were used to assess potential sources of heterogeneity.Results: Three observational studies included a total of 2,646 obese pregnant women and found that adiponectin was more likely to have a lower level in pregnant women with obesity [SMD=-0.32; 95% CI: -0.34-0.17, p=0.003] and leptin was more likely to be higher in obese pregnant women with PE rather than non-PE [SMD=0.53; 95% CI: -0.19-1.08, p<0.00001].Conclusions: Adiponectin levels were more likely to be lower in pregnant women with obesity in the PE group than in the non-PE group, and leptin levels were more likely to be higher.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 13","pages":"3922-3933"},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0